Alexander Lobo
Stern Investor Relations
Replay available
Inhibikase Therapeutics, Inc. (IKT) Q1 2024 Earnings Call
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Q1 2024 earnings conference call, held 2024-05-16. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Milton Werner
Chief Executive Officer
Garth Lees-Wolf
Chief Financial Officer
Ed White
Analyst, H.C. Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inhibikase Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.129 -- 00:00:05.333 and welcome to NHBK's Therapeutics First Quarter 2024 Financial 00:00:05.333 -- 00:00:10.417 Results Conference Call. At this time, all participants are in a listen-only 00:00:10.417 -- 00:00:15.441 mode. A brief question and answer session will follow the formal presentation. 00:00:15.441 -- 00:00:19.825 If anyone should require operator assistance during the conference, please press star 00:00:19.825 -- 00:00:25.515 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:25.515 -- 00:00:28.657 It is now my pleasure to introduce your host, Mr. 00:00:28.657 -- 00:00:32.159 Alexander Lobo, Stern Investor Relations. Thank you, Mr. 00:00:32.159 -- 00:00:35.140 Lobo. You may begin. 00:00:36.302 -- 00:00:41.105 Good morning, and welcome to Inhibit Case Therapeutics' first quarter 2024 financial 00:00:41.105 -- 00:00:44.107 results conference call and audio webcast. 00:00:44.107 -- 00:00:49.130 With me today is Dr. Milton Werner, Chief Executive Officer, and Garth Lees-Wolf, Chief 00:00:49.130 -- 00:00:51.631 Financial Officer. 00:00:51.656 -- 00:00:56.039 On May 15, Inhibit Case issued a press release announcing financial results for the first 00:00:56.039 -- 00:01:01.102 quarter ended March 31, 2024. We encourage everyone to read 00:01:01.102 -- 00:01:06.166 yesterday's press release, as well as Inhibit Case's quarterly report on Form 10-Q, which 00:01:06.166 -- 00:01:08.667 is being filed with the SEC. 00:01:08.667 -- 00:01:13.370 The company's press release and Form 10-Q are also available on Inhibit Case's website 00:01:13.370 -- 00:01:15.490 at inhibitcase.com. 00:01:15.973 -- 00:01:19.516 In addition, this conference call is being webcast through the investor relations section 00:01:19.516 -- 00:01:2...